Pharmaceuticals

Mon, 08/23/2010 - 15:00

Chase Sun Pharma to build new TCM and R&D facilities

Shanghai. August 23. INTERFAX-CHINA - Tianjin Chase Sun Pharmaceutical Co. Ltd. plans to invest RMB 62.87 million ($9.25 million) in new traditional Chinese medicine (TCM) material processing and testing facilities, as well as a new research and development (R & D) center, the company announced Aug. 23.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW